EH
REGN icon

Equitable Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Equitable Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Buy
1,829
+624
+52% +$478K 0.01% 861
2025
Q4 		$930K Buy
1,205
+363
+43% +$247K 0.01% 887
2025
Q3 		$473K Sell
842
-39
-4% -$22.1K ﹤0.01% 1100
2025
Q2 		$463K Sell
881
-44
-5% -$24.6K ﹤0.01% 1029
2025
Q1 		$587K Buy
925
+36
+4% +$24.8K 0.01% 868
2024
Q4 		$633K Sell
889
-217
-20% -$182K 0.01% 811
2024
Q3 		$1.16M Buy
1,106
+31
+3% +$34.5K 0.01% 638
2024
Q2 		$1.13M Buy
1,075
+55
+5% +$53.3K 0.01% 624
2024
Q1 		$982K Buy
1,020
+29
+3% +$27.6K 0.01% 627
2023
Q4 		$870K Buy
991
+30
+3% +$24.7K 0.01% 619
2023
Q3 		$791K Sell
961
-27
-3% -$21.2K 0.01% 602
2023
Q2 		$710K Buy
988
+21
+2% +$16.2K 0.01% 606
2023
Q1 		$795K Buy
967
+14
+1% +$10.6K 0.01% 533
2022
Q4 		$688K Buy
953
+312
+49% +$230K 0.01% 534
2022
Q3 		$442K Sell
641
-37
-5% -$23.3K 0.01% 588
2022
Q2 		$401K Sell
678
-45
-6% -$29.3K 0.01% 613
2022
Q1 		$505K Buy
+723
New +$457K 0.01% 569
2021
Q4 		– Sell
-458
Closed -$277K – 884
2021
Q3 		$277K Buy
+458
New +$284K ﹤0.01% 698

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Equitable Holdings's REGN Position: Q1 2026 in Review

Equitable Holdings increased its Regeneron Pharmaceuticals (REGN) stake by 52% in Q1 2026, buying an estimated $478K and bringing the position to 1,829 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #861.

Equitable Holdings first reported a position in REGN in Q3 2021 and has held it in 18 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Equitable Holdings held 1,829 shares of Regeneron Pharmaceuticals worth $1.41M as of Q1 2026.
  • Equitable Holdings bought 624 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $478K.
  • Regeneron Pharmaceuticals made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #861 holding.
  • Equitable Holdings first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.